Proteomics International Laboratories Ltd (Proteomics) works as a medical technology organization that finds new biopharmaceutical drugs. The company's products include the promarker pipeline and vitro diagnostic products. It outfits its exclusive proteomics-based technology stage to work in three coordinated regions: diagnostics, logical services and medication revelation. Proteomics is the large-scale mapping of the structure and function of proteins. The company created PromarkerD, a prescient test for the determination of diabetic kidney infection. It serves the drug business across Australia. Proteomics is headquartered in Nedlands, Western Australia, Australia.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Proteomics International Laboratories Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Proteomics International Laboratories Ltd Company Overview
- Proteomics International Laboratories Ltd Company Snapshot
- Proteomics International Laboratories Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Proteomics International Laboratories Ltd - Pipeline Analysis Overview
- Proteomics International Laboratories Ltd - Key Facts
- Proteomics International Laboratories Ltd - Major Products and Services
- Proteomics International Laboratories Ltd Pipeline Products by Development Stage
- Proteomics International Laboratories Ltd Pipeline Products Overview
- Diagnostic Test - Alzheimer's Disease
- Diagnostic Test - Alzheimer's Disease Product Overview
- Next Generation Diagnostic Test
- Next Generation Diagnostic Test Product Overview
- Promarker Test - Asthma And COPD
- Promarker Test - Asthma And COPD Product Overview
- Promarker Test - COVID-19
- Promarker Test - COVID-19 Product Overview
- Promarker Test - COVID-19 Dx
- Promarker Test - COVID-19 Dx Product Overview
- Promarker Test - Diabetic Retinopathy
- Promarker Test - Diabetic Retinopathy Product Overview
- Promarker Test - Giardia
- Promarker Test - Giardia Product Overview
- Promarker Test - Mesothelioma
- Promarker Test - Mesothelioma Product Overview
- Promarker Test - Oesophageal Cancer
- Promarker Test - Oesophageal Cancer Product Overview
- Promarker Test - Oxidative Stress
- Promarker Test - Oxidative Stress Product Overview
- PromarkerD
- PromarkerD Product Overview
- PromarkerD (CDx)
- PromarkerD (CDx) Product Overview
- PromarkerD LDT
- PromarkerD LDT Product Overview
- PromarkerEndo
- PromarkerEndo Product Overview
- Proteomics International Laboratories Ltd - Key Competitors
- Proteomics International Laboratories Ltd - Key Employees
- Proteomics International Laboratories Ltd - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Proteomics International Laboratories Ltd, Recent Developments
- Feb 01, 2024: Latest Results Validate Biomarkers for Promarkereso Blood Test for Oesophageal Adenocarcinoma
- Feb 01, 2024: Latest Results Validate Biomarkers for Promarkerendo Blood Test for Endometriosis
- Nov 22, 2023: US Medicare Confirms Reimbursement Price for Promarkerd
- Jul 20, 2023: Promarker Pipeline - Oesophageal Cancer Diagnostic Test Update
- May 03, 2023: Canagliflozin lowers PromarkerD diabetic kidney disease risk prediction scores
- Apr 17, 2023: Proteomics International Renews Its ISO 13485 Certification and ISO 17025 Accreditation
- Mar 15, 2023: Proteomics International to resubmit application for PromarkerD listing on Australian Medicare Benefits Schedule
- Feb 15, 2023: Proteomics International : Distribution agreement for PromarkerD in Britain extended
- Jan 03, 2023: Major milestone achieved as CPT PLA reimbursement code approved in the United States for PromarkerD
- Nov 11, 2022: PromarkerD patent granted in Hong Kong
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Proteomics International Laboratories Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Proteomics International Laboratories Ltd Pipeline Products by Equipment Type
- Proteomics International Laboratories Ltd Pipeline Products by Indication
- Proteomics International Laboratories Ltd, Key Facts
- Proteomics International Laboratories Ltd, Major Products and Services
- Proteomics International Laboratories Ltd Number of Pipeline Products by Development Stage
- Proteomics International Laboratories Ltd Pipeline Products Summary by Development Stage
- Diagnostic Test - Alzheimer's Disease - Product Status
- Diagnostic Test - Alzheimer's Disease - Product Description
- Next Generation Diagnostic Test - Product Status
- Next Generation Diagnostic Test - Product Description
- Promarker Test - Asthma And COPD - Product Status
- Promarker Test - Asthma And COPD - Product Description
- Promarker Test - COVID-19 - Product Status
- Promarker Test - COVID-19 - Product Description
- Promarker Test - COVID-19 Dx - Product Status
- Promarker Test - COVID-19 Dx - Product Description
- Promarker Test - Diabetic Retinopathy - Product Status
- Promarker Test - Diabetic Retinopathy - Product Description
- Promarker Test - Giardia - Product Status
- Promarker Test - Giardia - Product Description
- Promarker Test - Mesothelioma - Product Status
- Promarker Test - Mesothelioma - Product Description
- Promarker Test - Oesophageal Cancer - Product Status
- Promarker Test - Oesophageal Cancer - Product Description
- Promarker Test - Oxidative Stress - Product Status
- Promarker Test - Oxidative Stress - Product Description
- PromarkerD - Product Status
- PromarkerD - Product Description
- PromarkerD (CDx) - Product Status
- PromarkerD (CDx) - Product Description
- PromarkerD LDT - Product Status
- PromarkerD LDT - Product Description
- PromarkerEndo - Product Status
- PromarkerEndo - Product Description
- Proteomics International Laboratories Ltd, Key Employees
- Proteomics International Laboratories Ltd, Other Locations
- Glossary
- Proteomics International Laboratories Ltd Pipeline Products by Equipment Type
- Proteomics International Laboratories Ltd Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AusBiotech Ltd
- Medtronic Australasia Pty Ltd
- INOVIQ Ltd
